[Radiotherapy of oligometastatic pelvic node relapses in patients with prostate cancer].

Authors :: Supiot S
Doré M
Rio E
Source :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2017 Oct; Vol. 21 (6-7), pp. 495-497. Date of Electronic Publication: 2017 Aug 25.
Publication Year :: 2017
Abstract: The Oligopelvis 2 studies is based on the assumption that salvage pelvic radiotherapy may prolong the interval between the first and the second intermittent hormone therapy sequence in pelvic lymph node oligometastatic prostate cancer. This phase 3 study will compare intermittent hormone therapy (standard arm) alone or combined with salvage pelvic radiotherapy (experimental arm).<br /> (Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.)

Subjects :: Humans
Lymphatic Metastasis
Male
Pelvis
Research Design
Salvage Therapy
Lymphatic Irradiation
Neoplasm Recurrence, Local radiotherapy
Prostatic Neoplasms pathology
Prostatic Neoplasms radiotherapy

Language :: French
ISSN :: 1769-6658
Volume :: 21
Issue :: 6-7
Database :: MEDLINE
Journal :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Publication Type :: Academic Journal
Accession number :: 28847462
Full Text :: https://doi.org/10.1016/j.canrad.2017.07.017

Full Text Access

Tools